The show will be a part of the India Pharma Week, a marquee celebration catering to every need of the pharma community attendees
The Bulk Drug Parks to be developed under the scheme will provide common infrastructure facilities at one place thereby creating a robust ecosystem for the bulk drug manufacturing in the country and also reducing manufacturing cost significantly
India exported Bulk Drugs/Drug Intermediates worth Rs. 33,320 crore in financial year 2021-22.
India exported about Rs 33,321 crore and imported Rs 35,249 crore worth APIs and Bulk drugs in 2021-22.
JB, in its new avatar, emerges as the fastest growing pharmaceuticals company in India
The centre works with active pharmaceutical ingredients (APIs) and can utilize innovative concepts with model APIs
Pharma exports in 2021-22 sustain a positive growth despite global trade disruptions
Headwinds related to pricing pressures and rising raw material costs will result in some contraction in margins in Q4 FY22 and FY23
The two-day event will showcase achievements and address issues pertaining to the industry
The summit also saw the launch of two important reports- Multi-Regional Clinical Trials (MRCT) and Value of OTC in India
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
